AbbVie’s newer immunology drugs are offsetting Humira’s decline, sending stock up 5%
AbbVie Inc.’s stock rose 5% early Friday to lead S&P 500 gainers premarket, after the drug company beat fourth-quarter ...
Chevron logs its first refining loss in four years, sending stock lower
Chevron touted “record production” as well as stock buybacks and announced an increase in its quarterly dividend.